Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
about
Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literatureIn vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements.Immunological derangement in hypocellular myelodysplastic syndromes.Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).
P2860
Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoplastic myelodysplastic sy ...... pared to aplastic anemia (AA).
@en
Hypoplastic myelodysplastic syndrome
@nl
type
label
Hypoplastic myelodysplastic sy ...... pared to aplastic anemia (AA).
@en
Hypoplastic myelodysplastic syndrome
@nl
prefLabel
Hypoplastic myelodysplastic sy ...... pared to aplastic anemia (AA).
@en
Hypoplastic myelodysplastic syndrome
@nl
P2093
P1433
P1476
Hypoplastic myelodysplastic sy ...... pared to aplastic anemia (AA).
@en
P2093
Byoung Kook Kim
Dong Soon Lee
Eun Young Song
Hye Ryun Lee
Hyun Kyoung Kim
Myoung Hee Park
Seonyang Park
Sung-Soo Yoon
Youngil Koh
P304
P356
10.1016/J.LEUKRES.2010.03.001
P577
2010-04-27T00:00:00Z